NLS Global report

Financing - April 28, 2026

Ray Therapeutics raises USD 125 million, Novo Holdings doubles down on optogenetic eye gene therapy

The US company has closed an upsized, oversubscribed Series B to advance its optogenetic gene therapy pipeline for blinding retinal diseases with Novo Holdings reinforcing a strong Nordic investment footprint in late‑stage ophthalmology.

Global report - April 24, 2026

Biogen in agreement with TJ Biopharma

The companies have entered into a definitive agreement under which Biogen has agreed to acquire TJ Bio’s exclusive rights to felzartamab in the Greater China Region.

Clinical Trials - April 15, 2026

Promising results about new Lyme disease vaccine candidate

Pfizer and Valneva's Lyme disease vaccine candidate demonstrated strong efficacy in their Phase 3 VALOR trial.

Global report - April 14, 2026

New investigation about Merck’s tactics to sustain high prices

A global investigation led by journalists from the International Consortium of Investigative Journalists shows how Merck & Co has deployed a range of strategies to sustain high prices and stifle competition.

Acquisition - April 7, 2026

MSD to acquire Terns Pharmaceuticals

MSD and Terns Pharmaceuticals have entered into a definitive agreement under which MSD, through a subsidiary, will acquire Terns for an approximate equity value of USD 6.7 billion.

Global report - April 6, 2026

Flanders punches above its weight in European biotech

The Belgian region of Flanders has long been one of Europe’s most industrially dynamic regions. Its economy is anchored by advanced manufacturing, logistics, and a life science sector that consistently performs far above the region’s size.

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.